A Prospective, Cohort Study of SITOIGANAP to Treat Glioblastoma When Given in Combination With Granulocyte-Macrophage Colony-Stimulating Factor/Cyclophosphamide/Bevacizumab/Nivolumab or Granulocyte-Macrophage Colony-Stimulating Factor/Cyclophosphamide/Bevacizumab/Pembrolizumab in Patients Who Failed Prior Treatment With Surgical Resection, Radiation, and Temozolomide.

导出 LinkOut

翻译打印收藏纠错

第一作者： Daniela A,Bota

第一单位： Department of Neurology, University of California Irvine, Irvine, CA, United States.

作者： Daniela A,Bota ^[1] ; Thomas H,Taylor ^[2] ; Naomi,Lomeli ^[3] ; Xiao-Tang,Kong ^[3] ; Beverly D,Fu ^[4] ; Axel H,Schönthal ^[1] ; Samuel,Singer ^[1] ; Deborah T,Blumenthal ^[2] ; Frank M,Senecal ^[3] ; Helena,Linardou ^[1] ; Evangelos,Rokas ^[3] ; Dimitris G,Antoniou ^[5] ; Virgil E J C,Schijns ^[6] ; Thomas C,Chen ^[7] ; Joseph,Elliot ^[8] ; Apostolos,Stathopoulos ^[9]

作者单位： Department of Neurology, University of California Irvine, Irvine, CA, United States. ^[1] Department of Neurological Surgery, University of California Irvine, Irvine, CA, United States. ^[2] Chao Family Comprehensive Cancer Center, University of California Irvine, Irvine, CA, United States. ^[3] Department of Epidemiology and Biostatistics, University of California Irvine, Irvine, CA, United States. ^[4] Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States. ^[5] John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, United States. ^[6] Neuro-oncology Division, Tel-Aviv Sourasky Medical Center, Tel-Aviv University, Tel-Aviv, Israel. ^[7] Department of Hematology and Oncology, Northwest Medical Specialties, Tacoma, WA, United States. ^[8] Fourth Oncology Department and Comprehensive Clinical Trials Center, Metropolitan Hospital, Athens, Greece. ^[9] Department of Neurosurgery, Henry Dunant Hospital Center, Athens, Greece. ^[10] Epitopoietic Research Corporation (ERC), Gembloux, Belgium. ^[11] Epitopoietic Research Corporation (ERC), Pasadena, CA, United States. ^[12] Department of Neurosurgery, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States. ^[13] Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States. ^[14]

关键词 ERC1671 GBM vaccine SITOIGANAP immunotherapy recurrent glioblastoma

DOI 10.3389/fonc.2022.934638

PMID 35837107

发布时间 2022-11-19

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Frontiers in oncology

2022年12卷

934638页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

检索历史清除